Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
48
UGI Quote, Financials, Valuation and Earnings
Last price:
$36.04
Seasonality move
:
0%
Day range:
$35.61 - $36.59
52-week range:
$23.09 - $36.74
Dividend yield:
4.17%
P/E ratio:
14.79x
P/S ratio:
1.06x
P/B ratio:
1.54x
Volume:
1.3M
Avg. volume:
1.7M
1-year change:
46.54%
Market cap:
$7.7B
Revenue:
$7.2B
EPS (TTM):
$2.43
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.6B | $7.4B | $10.1B | $8.9B | $7.2B | |
| Revenue Growth (YoY) | -10.4% | 13.54% | 35.71% | -11.66% | -19.24% | |
| Cost of Revenues | $3.1B | $2.6B | $6B | $6.9B | $3.5B | |
| Gross Profit | $3.4B | $4.8B | $4.1B | $2B | $3.7B | |
| Gross Profit Margin | 51.99% | 64.9% | 40.9% | 22.3% | 51.05% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9B | $2B | $2B | $2.2B | $2.1B | |
| Other Inc / (Exp) | -$42M | -$35M | $78M | -$823M | -$302M | |
| Operating Expenses | $2.4B | $2.5B | $2.5B | $2.6B | $2.7B | |
| Operating Income | $1B | $2.3B | $1.6B | -$658M | $1B | |
| Net Interest Expenses | $311M | $293M | $310M | $356M | $367M | |
| EBT. Incl. Unusual Items | $667M | $2B | $1.4B | -$1.8B | $340M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $135M | $522M | $313M | -$335M | $71M | |
| Net Income to Company | $532M | $1.5B | $1.1B | -$1.5B | $269M | |
| Minority Interest in Earnings | -- | -- | -$1M | -- | -- | |
| Net Income to Common Excl Extra Items | $532M | $1.5B | $1.1B | -$1.5B | $269M | |
| Basic EPS (Cont. Ops) | $2.55 | $7.02 | $5.11 | -$7.16 | $1.27 | |
| Diluted EPS (Cont. Ops) | $2.54 | $6.92 | $4.97 | -$7.16 | $1.25 | |
| Weighted Average Basic Share | $208.9M | $209.1M | $209.9M | $209.8M | $211.3M | |
| Weighted Average Diluted Share | $209.9M | $212.1M | $215.8M | $209.8M | $215.3M | |
| EBITDA | $1.5B | $2.8B | $2.2B | -$926M | $1.3B | |
| EBIT | $989M | $2.3B | $1.7B | -$1.5B | $734M | |
| Revenue (Reported) | $6.6B | $7.4B | $10.1B | $8.9B | $7.2B | |
| Operating Income (Reported) | $1B | $2.3B | $1.6B | -$658M | $1B | |
| Operating Income (Adjusted) | $989M | $2.3B | $1.7B | -$1.5B | $734M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.6B | $3.5B | $3.1B | $2.5B | $2.7B | |
| Revenue Growth (YoY) | 15.79% | 34.29% | -10.39% | -20.57% | 8.07% | |
| Cost of Revenues | $1.3B | $1.5B | $2.1B | $1B | $1.3B | |
| Gross Profit | $1.3B | $2B | $958M | $1.4B | $1.4B | |
| Gross Profit Margin | 50.64% | 57.59% | 30.84% | 58.25% | 51.2% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $515M | $553M | $587M | $591M | $546M | |
| Other Inc / (Exp) | $28M | $16M | $2M | $12M | -$4M | |
| Operating Expenses | $636M | $664M | $703M | $720M | $665M | |
| Operating Income | $671M | $1.3B | $255M | $717M | $700M | |
| Net Interest Expenses | $78M | $82M | $93M | $100M | $102M | |
| EBT. Incl. Unusual Items | $621M | $1.3B | $164M | $629M | $594M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $132M | $332M | $54M | $133M | $115M | |
| Net Income to Company | $489M | $934M | $110M | $496M | $479M | |
| Minority Interest in Earnings | -- | -$1M | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $489M | $933M | $110M | $496M | $479M | |
| Basic EPS (Cont. Ops) | $2.34 | $4.44 | $0.52 | $2.36 | $2.23 | |
| Diluted EPS (Cont. Ops) | $2.33 | $4.32 | $0.51 | $2.30 | $2.19 | |
| Weighted Average Basic Share | $208.9M | $210.2M | $209.9M | $209.8M | $215M | |
| Weighted Average Diluted Share | $210.1M | $215.9M | $216.1M | $215.2M | $218.9M | |
| EBITDA | $825M | $1.5B | $389M | $867M | $834M | |
| EBIT | $699M | $1.3B | $257M | $729M | $696M | |
| Revenue (Reported) | $2.6B | $3.5B | $3.1B | $2.5B | $2.7B | |
| Operating Income (Reported) | $671M | $1.3B | $255M | $717M | $700M | |
| Operating Income (Adjusted) | $699M | $1.3B | $257M | $729M | $696M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.8B | $9.1B | $9.8B | $7.7B | $7.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3B | $4.1B | $7.6B | $3.9B | $3.5B | |
| Gross Profit | $3.8B | $5B | $2.2B | $3.7B | $3.8B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9B | $2.1B | $2.1B | -- | -- | |
| Other Inc / (Exp) | -$41M | -$28M | -$185M | -$611M | -$246M | |
| Operating Expenses | $2.4B | $2.6B | $2.6B | $2.7B | $2.6B | |
| Operating Income | $1.5B | $2.4B | -$379M | $1.1B | $1.2B | |
| Net Interest Expenses | $300M | $300M | $332M | $371M | $371M | |
| EBT. Incl. Unusual Items | $1.1B | $2.1B | -$896M | $71M | $602M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $227M | $567M | -$288M | $139M | $69M | |
| Net Income to Company | $886M | $1.5B | -$608M | -$68M | $533M | |
| Minority Interest in Earnings | -- | -$2M | $1M | -- | -- | |
| Net Income to Common Excl Extra Items | $886M | $1.5B | -$607M | -$68M | $533M | |
| Basic EPS (Cont. Ops) | $4.25 | $7.21 | -$2.89 | -$0.33 | $2.47 | |
| Diluted EPS (Cont. Ops) | $4.23 | $7.00 | -$2.93 | -$0.41 | $2.43 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.9B | $2.9B | -$21M | $1B | $1.6B | |
| EBIT | $1.4B | $2.4B | -$545M | $465M | $1B | |
| Revenue (Reported) | $6.8B | $9.1B | $9.8B | $7.7B | $7.3B | |
| Operating Income (Reported) | $1.5B | $2.4B | -$379M | $1.1B | $1.2B | |
| Operating Income (Adjusted) | $1.4B | $2.4B | -$545M | $465M | $1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | $6.1B | $5.9B | $4.6B | $4.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.1B | $3.6B | $5.3B | $2.2B | $2.2B | |
| Gross Profit | $2.4B | $2.5B | $611M | $2.4B | $2.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1B | $1.1B | $1.1B | $1.1B | $1B | |
| Other Inc / (Exp) | $16M | $23M | -$240M | -$28M | $28M | |
| Operating Expenses | $1.2B | $1.3B | $1.3B | $1.4B | $1.3B | |
| Operating Income | $1.2B | $1.3B | -$734M | $977M | $1.2B | |
| Net Interest Expenses | $156M | $163M | $185M | $200M | $204M | |
| EBT. Incl. Unusual Items | $1B | $1.1B | -$1.2B | $749M | $1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $241M | $286M | -$315M | $159M | $157M | |
| Net Income to Company | $792M | $838M | -$844M | $590M | $854M | |
| Minority Interest in Earnings | -- | -$2M | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $792M | $836M | -$844M | $590M | $854M | |
| Basic EPS (Cont. Ops) | $3.79 | $3.98 | -$4.02 | $2.81 | $3.97 | |
| Diluted EPS (Cont. Ops) | $3.77 | $3.86 | -$4.03 | $2.74 | $3.93 | |
| Weighted Average Basic Share | $417.7M | $419.8M | $419.8M | $419.6M | $429.9M | |
| Weighted Average Diluted Share | $419.7M | $425.6M | $426.1M | $430.8M | $434.6M | |
| EBITDA | $1.4B | $1.5B | -$711M | $1.2B | $1.5B | |
| EBIT | $1.2B | $1.3B | -$974M | $949M | $1.2B | |
| Revenue (Reported) | $4.5B | $6.1B | $5.9B | $4.6B | $4.7B | |
| Operating Income (Reported) | $1.2B | $1.3B | -$734M | $977M | $1.2B | |
| Operating Income (Adjusted) | $1.2B | $1.3B | -$974M | $949M | $1.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $336M | $855M | $405M | $241M | $213M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $652M | $880M | $1.1B | $878M | $709M | |
| Inventory | $241M | $469M | $665M | $433M | $411M | |
| Prepaid Expenses | $96M | $135M | $110M | $123M | $113M | |
| Other Current Assets | $59M | $101M | $120M | $127M | $69M | |
| Total Current Assets | $1.5B | $3.3B | $3.8B | $2B | $1.7B | |
| Property Plant And Equipment | $7B | $7.6B | $8B | $8.5B | $8.8B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.5B | $3.8B | $3.6B | $3B | $2.9B | |
| Other Intangibles | $677M | $583M | $500M | $443M | $391M | |
| Other Long-Term Assets | $854M | $831M | $755M | $988M | $1.1B | |
| Total Assets | $14B | $16.7B | $17.6B | $15.4B | $15.1B | |
| Accounts Payable | $475M | $837M | $891M | $613M | $544M | |
| Accrued Expenses | $162M | $181M | $147M | $142M | $196M | |
| Current Portion Of Long-Term Debt | $400M | $477M | $517M | $57M | $235M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $514M | $594M | $664M | $581M | $421M | |
| Total Current Liabilities | $1.8B | $2.3B | $2.4B | $2.3B | $2.1B | |
| Long-Term Debt | $6B | $6.3B | $6.5B | $6.5B | $6.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.8B | $11.2B | $11.5B | $11B | $10.7B | |
| Common Stock | $1.4B | $1.6B | $1.6B | $1.7B | $1.7B | |
| Other Common Equity Adj | -$147M | -$140M | -$380M | -$256M | -$253M | |
| Common Equity | $4.1B | $5.3B | $5.9B | $4.2B | $4.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $9M | $9M | $8M | $8M | $9M | |
| Total Equity | $4.1B | $5.5B | $6.1B | $4.4B | $4.4B | |
| Total Liabilities and Equity | $14B | $16.7B | $17.6B | $15.4B | $15.1B | |
| Cash and Short Terms | $336M | $855M | $405M | $241M | $213M | |
| Total Debt | $6.4B | $6.8B | $7B | $7.2B | $7.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $444M | $718M | $321M | $263M | $426M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.2B | $1.7B | $1.5B | $1.2B | $1.2B | |
| Inventory | $268M | $398M | $433M | $375M | $341M | |
| Prepaid Expenses | $175M | $211M | -- | -- | -- | |
| Other Current Assets | -- | -- | $189M | $203M | $150M | |
| Total Current Assets | $2.4B | $4.2B | $2.8B | $2.2B | $2.3B | |
| Property Plant And Equipment | $7B | $7.8B | $8.3B | $8.6B | $8.8B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.5B | $3.7B | $3.7B | $3B | $2.8B | |
| Other Intangibles | $640M | $545M | $472M | $415M | $362M | |
| Other Long-Term Assets | $924M | $832M | $852M | $1B | $1.1B | |
| Total Assets | $14.9B | $17.8B | $16.4B | $15.6B | $15.7B | |
| Accounts Payable | $627M | $915M | $757M | $579M | $605M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $391M | $577M | $515M | $54M | $18M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $874M | $1B | $1B | $857M | $828M | |
| Total Current Liabilities | $1.9B | $2.5B | $2.3B | $1.8B | $1.9B | |
| Long-Term Debt | $6B | $6.4B | $6.7B | $6.7B | $6.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $10.1B | $11.6B | $11.2B | $10.8B | $10.7B | |
| Common Stock | $1.4B | $1.6B | $1.7B | $1.7B | $1.7B | |
| Other Common Equity Adj | -$126M | -$178M | $15M | -$254M | -$268M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $9M | $10M | $9M | $9M | $9M | |
| Total Equity | $4.8B | $6.2B | $5.2B | $4.8B | $5B | |
| Total Liabilities and Equity | $14.9B | $17.8B | $16.4B | $15.6B | $15.7B | |
| Cash and Short Terms | $444M | $718M | $321M | $263M | $426M | |
| Total Debt | $6.3B | $7B | $7.2B | $7.1B | $7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $532M | $1.5B | $1.1B | -$1.5B | $269M | |
| Depreciation & Amoritzation | $484M | $502M | $518M | $532M | $551M | |
| Stock-Based Compensation | $15M | $21M | $15M | $17M | $8M | |
| Change in Accounts Receivable | -$98M | -$281M | -$431M | $303M | $105M | |
| Change in Inventories | -$5M | -$231M | -$224M | $247M | $32M | |
| Cash From Operations | $1.1B | $1.5B | $716M | $1.1B | $1.2B | |
| Capital Expenditures | $655M | $690M | $804M | $974M | $796M | |
| Cash Acquisitions | -$16M | -$423M | -$245M | -$125M | $1M | |
| Cash From Investing | -$649M | -$1.1B | -$1B | -$1.1B | -$792M | |
| Dividends Paid (Ex Special Dividend) | -$273M | -$282M | -$296M | -$308M | -$318M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $209M | $656M | $1.3B | $2B | $1.3B | |
| Long-Term Debt Repaid | -$535M | -$440M | -$978M | -$2B | -$1.3B | |
| Repurchase of Common Stock | -$38M | -- | -$38M | -$22M | -- | |
| Other Financing Activities | -- | -- | -$16M | -$16M | -$12M | |
| Cash From Financing | -$635M | $166M | -$51M | -$168M | -$506M | |
| Beginning Cash (CF) | $511M | $357M | $877M | $469M | $340M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$182M | $534M | -$347M | -$138M | -$116M | |
| Ending Cash (CF) | $357M | $877M | $469M | $340M | $228M | |
| Levered Free Cash Flow | $447M | $791M | -$88M | $133M | $386M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $489M | $934M | $110M | $496M | $479M | |
| Depreciation & Amoritzation | $126M | $128M | $132M | $138M | $138M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$205M | -$258M | $133M | -$11M | -$101M | |
| Change in Inventories | $7M | $145M | $187M | $61M | $45M | |
| Cash From Operations | $495M | $994M | $664M | $522M | $684M | |
| Capital Expenditures | $117M | $169M | $204M | $169M | $146M | |
| Cash Acquisitions | -$61M | -$198M | -$23M | -$28M | -- | |
| Cash From Investing | -$168M | -$361M | -$202M | -$188M | -$135M | |
| Dividends Paid (Ex Special Dividend) | -$69M | -$73M | -$75M | -$78M | -$80M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$26M | -$102M | $582M | $19M | $24M | |
| Long-Term Debt Repaid | -$31M | -$28M | -$1.1B | -$261M | -$291M | |
| Repurchase of Common Stock | -- | -- | -$10M | -- | -$17M | |
| Other Financing Activities | -- | -$4M | -$4M | -$4M | -- | |
| Cash From Financing | -$294M | -$209M | -$594M | -$324M | -$363M | |
| Beginning Cash (CF) | $446M | $358M | $544M | $302M | $246M | |
| Foreign Exchange Rate Adjustment | -$7M | -$9M | -$9M | -$4M | $6M | |
| Additions / Reductions | $33M | $424M | -$132M | $10M | $186M | |
| Ending Cash (CF) | $472M | $773M | $403M | $308M | $438M | |
| Levered Free Cash Flow | $378M | $825M | $460M | $353M | $538M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $886M | $1.5B | -$608M | -$68M | $533M | |
| Depreciation & Amoritzation | $494M | $509M | $524M | $544M | $552M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$282M | -$604M | $153M | $258M | -$52M | |
| Change in Inventories | -$81M | -$140M | -$34M | $56M | $34M | |
| Cash From Operations | $1.2B | $1.2B | $740M | $1.3B | $1.4B | |
| Capital Expenditures | $617M | $741M | $863M | $885M | $828M | |
| Cash Acquisitions | -$88M | -$548M | -$119M | -$100M | $23M | |
| Cash From Investing | -$679M | -$1.3B | -$970M | -$957M | -$806M | |
| Dividends Paid (Ex Special Dividend) | -$275M | -$289M | -$302M | -$314M | -$322M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $209M | $1.4B | $1.9B | $1B | $1.8B | |
| Long-Term Debt Repaid | -$399M | -$925M | -$1.6B | -$1.4B | -$1.8B | |
| Repurchase of Common Stock | -- | -- | -$60M | -- | -- | |
| Other Financing Activities | -- | -- | -$16M | -$16M | -- | |
| Cash From Financing | -$461M | $365M | -$122M | -$443M | -$453M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $46M | $329M | -$352M | -$76M | $130M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $569M | $494M | -$123M | $439M | $561M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $792M | $838M | -$844M | $590M | $854M | |
| Depreciation & Amoritzation | $250M | $257M | $263M | $275M | $276M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$620M | -$943M | -$359M | -$404M | -$561M | |
| Change in Inventories | -$27M | $64M | $254M | $63M | $65M | |
| Cash From Operations | $646M | $400M | $424M | $641M | $848M | |
| Capital Expenditures | $304M | $355M | $414M | $325M | $357M | |
| Cash Acquisitions | -$73M | -$198M | -$72M | -$47M | -$25M | |
| Cash From Investing | -$357M | -$515M | -$473M | -$353M | -$367M | |
| Dividends Paid (Ex Special Dividend) | -$138M | -$145M | -$151M | -$157M | -$161M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $30M | $724M | $1.3B | $409M | $899M | |
| Long-Term Debt Repaid | -$67M | -$552M | -$1.2B | -$565M | -$990M | |
| Repurchase of Common Stock | -- | -- | -$22M | -- | -$17M | |
| Other Financing Activities | -- | -$8M | -$8M | -$8M | -- | |
| Cash From Financing | -$174M | $25M | -$46M | -$321M | -$268M | |
| Beginning Cash (CF) | $803M | $1.2B | $1B | $642M | $474M | |
| Foreign Exchange Rate Adjustment | -- | -$14M | $29M | $1M | -$3M | |
| Additions / Reductions | $115M | -$90M | -$95M | -$33M | $213M | |
| Ending Cash (CF) | $918M | $1.1B | $947M | $610M | $684M | |
| Levered Free Cash Flow | $342M | $45M | $10M | $316M | $491M | |
Get UGI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UGI
Sector
P/E ratio
14.79x
14.77x
PEG ratio
--
0.35x
P/B ratio
1.54x
1.44x
Price / LTM sales
1.06x
1.58x
Growth Metrics
UGI
Sector
Revenue growth
8.07%
2.79%
Earnings growth
-4.78%
-0.57%
Revenue (5-year growth)
-0.3%
4.48%
Earnings forecast
-$0.09
$0.39
Profitability
UGI
Sector
Profitability FY 2024
$3.7B
$1.3B
Return on invested capital
4.52%
3.5%
Return on assets
3.46%
2.53%
Return on equity
11.35%
8.06%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
6
Estimated Next Earnings Date
Aug
6
Balance Sheet
UGI
Sector
Total cash
$426M
$406.3M
Short term investments
--
$97.6M
Total assets
$15.1B
$11.2B
Long term debt
$7B
$3.2B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
